Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact

Anna A. Schönherz(Aalborg University Hospital), Karen Dybkær(Aalborg University Hospital), Anne Stidsholt Roug(Aalborg University Hospital), Lasse Hjort Jakobsen(Aalborg University Hospital), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Marianne Tang Severinsen(Aalborg University Hospital), Alexander Schmitz(Chr. Hansen (Denmark)), Hans Erik Johnsen(Herlev Hospital), Julie Støve Bødker(Chr. Hansen (Denmark)), Paw Jensen(Aalborg University Hospital), Martin Bøgsted(Chr. Hansen (Denmark)), Rasmus Froberg Brøndum(Aarhus University)

PLoS ONE

April 23, 2020

10.1371/journal.pone.0229593

Cited by 4

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

|Leukemia|2015|256